Skip to content

Oxygen Tension on Human Embryonic Development

Impact of Low Versus Atmospheric Oxygen Tension on Human Embryo Development : A Prospective Randomized Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03964805
Acronym
EmbryOx
Enrollment
773
Registered
2019-05-28
Start date
2016-09-01
Completion date
2018-12-01
Last updated
2019-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Embryo Culture, Hypoxia, Infertility

Keywords

Embryo culture, oxygen tension,, embryo quality,, extended culture

Brief summary

In mammals, uterine environment is at low oxygen concentration (2-8% O2). Thus, human embryo culture under low O2 tension (5%) is now recommended by European Society of Human Reproduction and Embryology (ESHRE) revised guidelines for good practices in in vitro fertilization (IVF) labs. Indeed, hypoxia seems to improve embryo quality at cleavage and blastocyst stages, presumably by reducing damages of oxidative stress (OS). Nevertheless, recent meta-analyses concluded only with a low evidence to a superiority of hypoxia on IVF/ICSI outcomes. Furthermore, a study on mouse embryos suggested a negative impact of OS only at cleavage stage. The aim of the present prospective randomized study was to investigate this hypothesis for the first time in human embryos.

Detailed description

In mammals, uterine environment is at low oxygen tension, between 2 and 8% O2 . However, most IVF labs perform embryo culture at atmospheric tension (around 20% O2). Several randomized studies in human embryos have reported the superiority of hypoxia (5%) in terms of embryo quality and blastulation rates. This fact might be explained by a more physiological environment, probably inducing a decrease in oxidative stress (OS), which has a harmful impact on embryo development. Other studies have also suggested that before compaction, OS damages might be irreversible. Wale et Gardner have investigated this impact of oxygen tension on mouse embryo development, by comparing four culture conditions: (i) group 1: culture exclusively at 5% O2 ; (ii) group 2: culture at 5% from Day 0 to Day 2, then at 20% from Day 2 to Day 4; (iii) group 3: at 20% then at 5% from Day 2; (iv) and group 4: culture exclusively at 20% Interestingly, no difference in terms of blastulation had been reported between groups 1 and 2, suggesting the OS might impact only at cleavage stage, and that switching culture under atmospheric conditions from Day 2/3 might not influence embryo development thereafter. Hence, all those investigations suggest that embryo culture using trigas incubators (5% O2, 6% CO2 and 89% N2) would be preferable. However, this system is very expensive, notably due to a high N2 consumption, and requires a more complicated logistics (e.g. N2 levels monitoring). Yet, Wale and Gardner's results imply that sequential culture conditions (trigas from Day 0 to Day 2/3, then conventional incubator at 20% O2 until blastocyst stage) could be an valuable option, reducing the costs and, essentially, without any detrimental impact on embryo development. The present study has two main objectives: (i) to confirm the improvement in embryo quality under low oxygen tension and (ii) to demonstrate the negative impact of OS only at cleavage stage in human embryos, as assumed by Wale and Gardner. For that purpose, we designed an original prospective randomized study comparing three culture conditions: (i) culture excusively at 20% O2 (Day 0 to Day 6) (Group A); (ii) culture exclusively at 5% O2 (Day 0 to Day 6) (Group B); (iii) culture at 5% from Day 0 to Day 3, then at 20% from Day 3 to Day 6) (Group C). Inclusion criteria and outcome measures are detailed in the following sections.

Interventions

culture excusively at 20% O2 (Day 0 to Day 6)

culture excusively at 5% O2 (Day 0 to Day 6)

OTHER20 % and 5 % oxygen

culture at 5% from Day 0 to Day 3, then at 20% from Day 3 to Day 6)

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 39 Years
Healthy volunteers
No

Inclusion criteria

* Age: 18 - 39 years * IVF / ICSI Attempt with Ejaculated Sperm Sperm (Fresh or Frozen) * At least 8 oocytes retrieved in total * Good understanding of the protocol by the patient * Informed and consentment signed of the couple

Exclusion criteria

* \- Hydrosalpinx

Design outcomes

Primary

MeasureTime frameDescription
Embryo quality at Day 2 between groups A and B.Day 2Embryo morphology is qualified as the number of blastomeres, degree of cytoplasmic fragmentation, regularity of the cells and presence/absence of multinucleated blastomeres. Day 2 top-quality embryos are defined as 4 regular blastomeres, \<20% cytoplasmic fragmentation, no multinucleations.mbryos are defined as 4/8 regular blastomeres, \<20% cytoplasmic fragmentation, no multinucleations.
Embryo quality at Day 3 between groups A and B.Day 3Embryo morphology is qualified as the number of blastomeres, degree of cytoplasmic fragmentation, regularity of the cells and presence/absence of multinucleated blastomeres. Day 3 top-quality embryos are defined as 8 regular blastomeres, \<20% cytoplasmic fragmentation, no multinucleations.
Embryo quality at blastocyst stage (Day 5) between groups A, B and C.Day 5Blastocyst morphology is assessed according to Gardner and Schoolcraft's classification: degree of blastocele expansion (graded from B1 to B6), inner cell mass and trophectoderm morphology (both graded A, B or C). Day 5 top quality blastocyst are defined as ≥B4AA/AB/BA.
Embryo quality at blastocyst stage (Day 6) between groups A, B and C.Day 6Blastocyst morphology is assessed according to Gardner and Schoolcraft's classification: degree of blastocele expansion (graded from B1 to B6), inner cell mass and trophectoderm morphology (both graded A, B or C). Day 5 top quality blastocyst are defined as ≥B4AA/AB/BA.

Secondary

MeasureTime frameDescription
Clinical pregnancy rate4-5 weeks after transferPercentage of pregnancies diagnosed by ultrasonographic visualization of at least one gestational sac with fetal heart beat per embryo transfer
Fertilization rateDays 1Percentage of oocytes fertilized per oocyte inseminated, assessed at Day 1
Miscarriage rate4-5 weeks after transfer
Early cleavage rate25 hours after inseminationPercentage of embryos at the 2-cell stage per oocyte fertilized, assessed 25 hours after insemination
Useable embryo rateDays 2/3; 5/6Percentage of embryos transferred and/or frozen per embryo
Implantation rate4-5 weeks after transferNumber of gestational sacs with fetal heart beat detected per embryo transferred

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026